NHGRI's Division of Intramural Research will present the 13th Jeffrey M. Trent Lecture in Cancer Research Wednesday, Sept. 6, 2017, at the Lipsett Amphitheater, Building 10, NIH. Katherine A. Janeway, M.D., MMSc, the clinical director of the Solid Tumor Program at Dana Farber-Boston/Children's Cancer and Blood Disorders Center, will deliver the lecture Bringing Genomics to the Pediatric Oncology Clinic: Diagnosis, Treatment Selection and Rational Clinical Trial Design.
The National Human Genome Research Institute (NHGRI) and other institutes at the National Institutes of Health recently participated in a high-energy science communications contest called the Three-Minute Talk (TmT). NHGRI's Ryan Johnson came away with a first place win after the finals on June 29, 2017.
Cancer patients were a little more likely to survive for five years or more after chemotherapy if they interacted during chemotherapy with other patients who also survived for five years or more, according to a new study by researchers at the National Human Genome Research Institute, part of the National Institutes of Health, and the University of Oxford in the United Kingdom. The findings were published online July 12, 2017, in the journal Network Science.
An international team of researchers has identified the genomic mutations for Carey-Fineman-Ziter (CFZS) syndrome, a very rare, inherited muscle disorder. Their findings provide insight into the development of an embryo's muscles and the regeneration of muscle cells after injury. The study was published today July 6, 2017 in Nature Communications.